Received Nov 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | NA4452 | — |
Redness, swell, itching, and pain in area below and to the front of the arm from the injectioan site.; Redness, swell, itching, and pain in area below and to the front of the arm from the injectioan site.; Redness, swell, itching, and pain in area below and to the front of the arm from the injectioan site.; Redness, swell, itching, and pain in area below and to the front of the arm from the injectioan site.; Brain fog; Great fatigue/extreme fatigue/fatigue unique/extreme tiredness; This is a spontaneous report received from a Consumer or other non HCP. A 64-year-old female patient (not pregnant) received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), on 23Oct2025 as dose 1, single (Lot number: NA4452) at the age of 64 years for covid-19 immunisation. The patient also took a Sanofi Pasteur product with lot number: UT8826LA, on 23Oct2025, on left arm. The patient's relevant medical history included: "Dry eye" (unspecified if ongoing); "arthritis of knees and back" (unspecified if ongoing); "arthritis of knees and back" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: BRAIN FOG (non-serious) with onset 24Oct2025 at 02:30, outcome "recovering"; FATIGUE (non-serious) with onset 24Oct2025 at 02:30, outcome "recovering", described as "Great fatigue/extreme fatigue/fatigue unique/extreme tiredness"; VACCINATION SITE ERYTHEMA (non-serious), VACCINATION SITE SWELLING (non-serious), VACCINATION SITE PRURITUS (non-serious), VACCINATION SITE PAIN (non-serious) all with onset 24Oct2025 at 02:30, outcome "recovering" and all described as "Redness, swell, itching, and pain in area below and to the front of the arm from the injectioan site.". Therapeutic measures were taken as a result of vaccination site erythema, vaccination site swelling, vaccination site pruritus, vaccination site pain, brain fog, fatigue. Additional information: Reported events of redness, swell, itching, and pain in area below and to the front of the arm from the injection site. Developed <12 hours after injection, increased on second day, still have pain and itching at this site 9 days after injection and must limit use of arm. Great fatigue for more than two days. Brain fog, extreme fatigue first 24 hours (have had after every Covid vaccine dose). Second day continued fatigue unique, continued extreme tiredness for 3 more days (total 5 days). Treatment received for the adverse events included antihistimine (Allegra), and hydrocortisone.
Medical History/Concurrent Conditions: Back arthritis; Dry eye; Knee arthritis